期刊文献+

先天性心脏病封堵术后的血小板减少症及对策 被引量:5

下载PDF
导出
摘要 血小板减少是先天性心脏病经导管封堵术后的常见并发症。在3种常见的先天性心脏病中,房间隔缺损和动脉导管未闭患者术后血小板减少的发生率显著高于室间隔缺损患者。女性、植入较大的封堵器、术后残余分流以及肺动脉压增高则是血小板减少的主要危险因素。其发生机制可能与封堵器结构、应用阿司匹林等相关。该文就先天性心脏病经导管封堵术后血小板数量和功能变化的特点及处理策略作一综述。
出处 《国际心血管病杂志》 2014年第3期161-162,166,共3页 International Journal of Cardiovascular Disease
基金 国家自然科学基金(31271381) 长海医院"1255"转化医学项目(CH125550200)
  • 相关文献

参考文献12

  • 1Li P, Chen F, Zhao X, et al. Occurrence and clinical significance of in hospital acquired thrombocytopenia in patients undergoing transcatheter device closure for congenital heart defect [J]. ThrombRes, 2012,130(6):882- 888.
  • 2Zhou D, Zhang X, Pan W, et al. Decline in platelet count after perculaneous transeatheter closure of congenital heart disease [J]. Acta Cardiol, 2013,68(4) :373 -379.
  • 3Zeng XC, Wu WF, Huang K, et al. Enhanced prothrombin formation and platelet activation in Chinese patients after transcatheter closure of atrial septal defect [J]. Clin Cardiol, 2010,33(7) :E6- E9.
  • 4Knepp MD, Rocchini AP, Lloyd TR, et al. Long term follow up of secundum atrial septal defect closure with the amplatzer seplal occluder [J]. Congenit Heart Dis, 2010,5(1):32 -37.
  • 5Zhang P, Zhu XY. Severe thrombocytopenia complicating transcatheter occlusion of a patent ductus arteriosus [J]. J Invasive Cardiol, 2013,25(5) :E88- E92.
  • 6Yu MI., Huang XM, Wang JF, et al. Safety and efficacy of transcatheter closure of large patent ductus arteriosus inaduhs with a seII expandable occiuder [J]. Heart Vessels, 2009,24 (6) : 440-445.
  • 7Lee GM, Arepally GM. Diagnosis and management of heparin induced thrombocytopenia [J]. Hematol Oncol Clin North Am, 2013,27(3):541- 563.
  • 8Vales L, Kanei Y, Ephrem G, et al. fntra-aortic balloon pump use and outcomes with current therapies [J]. J Invasive Cardiol, 2011,23(3) :116-119.
  • 9De Labriolle A, Bonello L, Lemesle G, et al. Decline in platelet count in patients treated by percutaneous coronary intervention: definition, incidence, prognostic importance, and predictive faetors [J]. Eur Heart J, 2010, 31 (9): 1079-1087.
  • 10Bream-Rouwenhorst HR, Hobbs RA, Horwitz PA. Throm- bocytopenia in patients treated with heparin, combination antiplatelet therapy, and intra-aortic balloon pump counterpulsation [J]. J lnterv Cardiol, 2008, 21 (4): 350- 356.

同被引文献37

  • 1解启莲,张密林,王震.动脉导管未闭患儿介入封堵术后并发血小板减少症三例[J].中华医学杂志,2005,85(36):2532-2532. 被引量:13
  • 2Baruteau AE, Hascoet S, Baruteau J, et al. Transcatheter closure of patent ductus arteriosus: past, present and future. Arch Cardiovasc Dis, 2014, 107: 122-132.
  • 3Schubert S, Kainz S, Peters B, et al. Interventional closure of atrial septal defects without fluornscnpy in aduh and pediatric patients. Clin Res Cardiol, 2012, 101: 691-700.
  • 4Marenzi G, Lauri G, Assanelli E, et al. Contrast-induced nephropathy in patients undergoing primary angioplasty for acute myocardial infarction. J Am Coil Cardiol, 2004, 44: 1780-1785.
  • 5Pnrstmann W, Wicrny L, Warnke H. Closure of persistent ductus arteriosus without thoracotomy. German Medical Monthly, 1967, 12: 259-261.
  • 6Zahn EM, Nevin P, Simmons C, et al. A nvel technique for transcatheter patent ductus arteriosus closure in extremely preterm infants using commercially available technology. Catheler Cardiovasc lnterv, 2014, 85: 240-248.
  • 7Hongxin L, Wenbin G, Zhu M, et al. New minimally invasive technique of perpuhnonary device closure of patent ductus arteriosus through a parasternat approach. Ann Thorac Surg, 2012, 93: 862-868.
  • 8Jung JW. Do we have to close residual patent ductus arteriosus after surgery or transcalhcter intervention? Korean Cite J, 2011, 41: 639- 640.
  • 9Zhang P, Zhu X Y. Severe thrombocytopenia complicating transcatheter occlusion of a patent ductus arteriosus [J]. Invasive Cardiol, 2013, 25(5): E88-E92.
  • 10张戈军,蒋世良,凌坚,赵世华,黄连军,徐仲英,金敬琳,吕建华,吴文辉.应用Amplatzer血管塞封堵动脉导管未闭及初步疗效评价[J].中国循环杂志,2008,23(4):260-262. 被引量:5

引证文献5

二级引证文献23

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部